368 filings
Page 2 of 19
EFFECT
qaxqdh8
2 Feb 24
Notice of effectiveness
12:15am
424B3
enlfuwt7eu
2 Feb 24
Prospectus supplement
12:00am
CORRESP
5eb6sv
30 Jan 24
Correspondence with SEC
12:00am
DEF 14C
iuyfgmpnxhlk nr5y5
29 Jan 24
Information statement
8:00am
UPLOAD
rhmw52dsdg7exmbyof
29 Jan 24
Letter from SEC
12:00am
PRE 14C
belrgca0
17 Jan 24
Preliminary information
5:05pm
8-K
jj9j164h8uc 7vk9z5
12 Jan 24
Submission of Matters to a Vote of Security Holders
6:01am
8-K
v3f8vd1 wx
8 Jan 24
Entry into a Material Definitive Agreement
5:28pm
4
3zrx2jy
3 Jan 24
Change in insider ownership
4:27pm
SC 13G/A
b656luvouvc9axnlxun
2 Jan 24
AVENUE THERAPEUTICS / SABBY MANAGEMENT ownership change
3:45pm
SC 13G/A
3jvy8033
13 Dec 23
AVENUE THERAPEUTICS / Davidow Robert L ownership change
4:03pm
4
eo8pm9282
13 Dec 23
AVENUE THERAPEUTICS / Robert L Davidow ownership change
4:02pm
SC 13G
pxbrk 64rb4n
28 Nov 23
AVENUE THERAPEUTICS / Davidow Robert L ownership change
4:05pm
3
k89m0b g0ttpy10boxjf
28 Nov 23
AVENUE THERAPEUTICS / Robert L Davidow ownership change
4:01pm
8-K
4q90jzh3ttqubqv yjwr
24 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
1:19pm
8-K
6p2t9
13 Nov 23
Avenue Therapeutics Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights
4:10pm
8-K
h75ir rri9
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
424B4
o8n357cri2
2 Nov 23
Prospectus supplement with pricing info
9:00am